Identification of Prognosis-related RBPs to Reveal the Role of RNA Binding Proteins in the Progression and Prognosis of Wilms’ Tumor

Background: RNA-binding proteins (RBPs), the ubiquitous regulators that can bind to RNA, mediate the function of RNA in the process of its maturation, translation, transport and localization [1, 2]. Despite the various key functions of RBPs in posttranscriptional events, the mechanism of their influence on Wilms’ tumor has not been well elucidated. So we construct the research to identify several RBPs related to Wilmes’ tumor progression and prognosis, for the better understanding of RBPs’ role in the occurrence and development of Wilmes’ tumor, and to provide effective reference targets for new drug development.MethodsA total of 127 samples of different clinical characteristics including gender, race and stage were selected from TCGA to carry out our study. After the gene functional enrichment pathways, univariate Cox regression analysis and lasso regression analysis were performed to test the prognostic effect of the differentially-expressed genes and establish the prognostic index . Further Cox regression analyses were utilized to identify the independence of our model and to analyze the relationship between our model and clinical parameters. What’s more, gene set enrichment analysis (GSEA) was also performed to elucidate the biological characteristics of genes involved in Wilms’ tumor. P< 0.05 was considered to be statistically significant.Results26 RBPs were statistically correlated with Wilms’ tumor. After the construction of a prognostic index , patients were divided into high-and low-risk scores group. Kaplan-Meier (K-M) analyses showed that patients with high risk scores possessed poorer survival probability than patients with low risk scores in both training group and test group. Furthermore, multivariate Cox regression analysis explored the relationship between our prognostic model and clinical parameters and confirmed that our model was an independent predicted factor for Wilms’ tumor. ConclusionOur study clarifies the application of RBPs in the prognosis of Wilms’ tumor. We are confident that our risk scoring model can provide ideas for the development of new targets for broad-spectrum anticancer drugs and has great potential in clinical practice.Trial registrationretrospectively registered